Press Room

Event

2024 AIChE Annual meeting

Start
Sunday, October 27, 2024 - 08:00
End
Thursday, October 31, 2024 - 18:00
Location: San Diego, United States

Meet Hovione team at the 2024 AIChE Annual Meeting and find their exciting presentations and Hovione’s latest research and innovations. The AIChE Annual Meeting is an educational forum covering a wide range of topics relevant to cutting-edge research, new technologies, and emerging growth areas in chemical engineering. We look forward to meeting academic and industry experts and exchanging knowledge.

 

Date: October 28, 2024

Oral Presentation

Title: High Pressure Reaction Kinetic Modeling: Leveraging Single Data-Rich Experiment
Presenting Author: Ines Rocha – Scientist, Process Scale-up

9:45 AM - 10:06 AM
Room 29C (Upper Level, SDCC)

Oral Presentation

Title: Integrating Amorphous Solid Dispersions (ASDs) in a PBPK Software
Presenting Author: Pedro Monteiro – Senior Scientist, Formulation Development

10:06 AM - 10:27 AM
Room 29D (Upper Level, SDCC)

Oral Presentation

Title: Comprehensive Powder Flow Characterization with Reduced Testing
Presenting Author: Maria Paisana – Senior Scientist, Lead Analytical Scientists

12:50 PM - 1:10 PM
Sapphire 400B (4, Hilton Bayfront)

Oral Presentation

Title: Bayesian Optimization Applied to Chemical Reaction Optimization: Human-in-Loop and Cdmo Perspective
Presenting Author: Ines Rocha – Scientist, Process Scale-up

12:50 PM - 1:10 PM
Room 29D (Upper Level, SDCC)

 

Date: October 29, 2024

Oral Presentation

Title: Tswg Development and Scale up from Laboratory Benchtop Experiments
Presenting Author: Ricardo Sousa – Senior Scientist, Formulation Development

8:30 AM - 8:45 AM
Cobalt 520 (5, Hilton Bayfront)

Oral Presentation

Title: Scaling Continuous Powder Blenders: The Length-Scale Problem
Presenting Author: Scientific Fellow, Continuous Tableting

1:06 PM - 1:24 PM
Sapphire Ballroom M (4, Hilton Bayfront)

 

Date: October 30, 2024

Oral Presentation

Title: Path to Commercial Reality of Continuous Manufacturing - a Cdmo Perspective
Presenting Author: Jose Luis Santos – R&D Director, Technology Intensification

9:45 AM - 10:06 AM
Room 29C (Upper Level, SDCC)

Oral Presentation

Title: Methodology for Rapid Development of a Continuous Loss-in-Weight Feeding Process
Presenting Author: Ana Martins – PhD Student

1:12 PM - 1:33 PM
Room 29C (Upper Level, SDCC)

Poster Presentation

Title: Direct Scale-up of a Dry Granulation Process Using a Material Lean Approach at Lab-Scale
Presenting Author: Ricardo Sousa – Senior Scientist, Formulation Development

10:06 AM - 10:27 AM
Exhibit Hall GH (Ground Level, SDCC)

 

 

Date: October 31, 2024

Oral Presentation

Title: Formulating Amorphous Solid Dispersions into Oral Dosage Forms: A Fast to Market Integrated Approach
Presenting Author: Patricia Cruz

12:51 PM - 1:12 PM
Room 29C (Upper Level, SDCC)

Oral Presentation

Title: Leveraging COSMO-RS for Chemical Development and Scale-up in the Pharmaceutical Industry
Presenting Author: Ines Rocha – Scientist, Process Scale-up

3:30 PM - 3:48 PM
Room 30E (Upper Level, SDCC)

 

 

Let’s discuss your project together.

schedule a meeting
https://go.hovione.com/l/47122/2014-08-06/9grc

 

 

 

Find more about AIChE Annual Meeting

 

 

You might be interested in:

Drug Substance at Hovione

Your partner in custom development and manufacturing of APIs.

The Leader in Spray Drying

Know how to overcome your solubility issues with the best scale-up science.

The Future is Continuous

Meet our experts and find out if Continuous Tableting is right for your product.

Industrialization of Innovative Platforms

Learn more about our Large-scale GMP-compliant platforms that support your project from development to commercialization. 

Also in the Press Room

See All

Hovione’s Eunice Costa Shares Insights on Inhaled Medicine Formulation in Pharmaceutical Technology eBook The demand for efficient inhalation therapies is higher than ever. At Hovione we are focusing on particle size, dispersion performance, and formulation integrity to ensure optimal bioavailability and patient outcomes.  To learn more about or work, do not miss the contribution of Eunice Costa, our R&D Director for Inhalation & Advanced Drug Delivery, in the latest Pharmaceutical Technology eBook – “Trends in Formulation”.  In her interview, Eunice discusses key challenges and considerations in formulating inhaled medicines, emphasizing the importance of excipient selection, device compatibility, and patient-centric design for successful drug delivery to the lungs. With respiratory diseases at the forefront, especially following the COVID-19 pandemic, the demand for efficient inhalation therapies is higher than ever. Eunice sheds light on how Hovione is tackling these demands by focusing on particle size, dispersion performance, and formulation integrity to ensure optimal bioavailability and patient outcomes. Explore Eunice Costa’s full insights on this crucial area of drug development in Pharmaceutical Technology's September 2024 eBook. This resource provides an in-depth look into the complexities of inhaled drug formulations and the exciting innovations shaping the future of respiratory treatments.   Read the full article at Pharmaceutical Technology eBook Read the Trends in Formulation eBook at PharmTech  

Article
Excipient and delivery device selection play crucial roles in the formulation of inhaled drugs.

Formulating Inhaled Medicines

Sep 24, 2024

Lisbon, Portugal – Hovione, the specialist integrated pharma CDMO and leader in spray drying and particle engineering, today announced its commitment to setting Science-Based Targets (SBTs) in line with the Paris Agreement. This ambitious step underscores the company’s dedication to addressing climate change and driving sustainability across its operations. By committing to SBTs, Hovione joins a growing number of businesses taking concrete actions to reduce greenhouse gas emissions. This initiative aligns with the company’s broader sustainability strategy and reinforces its commitment to scientific excellence. “At Hovione, we believe in science and in best practices. And this clearly applies to our sustainability agenda.”, said Jean-Luc Herbeaux, CEO of Hovione. We made the decision to drive our GHG emissions down using a science-based target setting process, which will help us drive sustainability across our operations by laying out a clearly defined path to reduce emissions in line with the Paris Agreement goals. We believe that by setting ambitious targets and implementing concrete actions, we can make a positive impact on the planet while driving innovation and growth.” Hovione will work closely with the Science Based Targets initiative (SBTi) to develop and validate its emission reduction targets. The company will provide regular updates on its progress towards achieving these goals. As part of its commitment to sustainability and transparency to stakeholders, the company will enhance its Ecovadis rating. Ecovadis, a leading sustainability assessment platform in the pharmaceutical industry, provides a comprehensive evaluation of a company’s environmental, social, and ethical performance, well aligned with Hovione’s sustainability ambitions.  Hovione remains dedicated to operating responsibly and contributing positively to society and the environment. The company will continue to implement sustainable practices across its operations and innovate to further improve its sustainability rating.   Learn more about Science Based-Targets  

News
Hovione commitment to setting SBTs in line with the Paris Agreement

Hovione Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions

Sep 09, 2024

The partnership with Higuchi forms part of Hovione´s global expansion plans and marks a significant milestone in advancing Hovione's presence in the Japanese market.    Under the terms of the agreement, Higuchi will promote Hovione's pharmaceutical service business throughout Japan, using their extensive experience to enhance brand visibility and attract new clientele across the Japanese pharmaceutical landscape.  “This strategic collaboration underscores Hovione's dedication to delivering innovative solutions and exceptional service to its customers,” said Yuken Kyoyama. “Our partnership with Higuchi will help to show customers in Japan how Hovione can meet their needs.”    Learn more about our business in Japan and visit our website hovione.co.jp    

News
Hovione proudly announces its collaborative venture with Higuchi.

Hovione forges strategic partnership with Higuchi to further strengthen its presence in Japan

Jul 04, 2024

Also in Events

See All